Professional Summary

Professional Overview

Lisa Wax is a seasoned regulatory affairs executive with over 25 years of experience in the biopharmaceutical industry. As the VP of Regulatory Affairs at IGM Biosciences, she is responsible for leading the company's global regulatory strategy and ensuring seamless product development and approval processes.

Experience Summary

Current Role

In her current role as VP of Regulatory Affairs at IGM Biosciences, Lisa is integral to the company's success in developing innovative therapies for cancer and other life-threatening diseases. She oversees a team of regulatory professionals and collaborates closely with cross-functional partners to navigate complex regulatory landscapes and secure timely approvals for IGM's pipeline of novel immunotherapies.

Career Progression

Prior to joining IGM, Lisa held several senior-level regulatory affairs positions at leading biopharmaceutical companies, including AbbVie, FibroGen, Genitope, and Genentech. Throughout her career, she has demonstrated a strong track record of driving regulatory strategies that have enabled the successful development and commercialization of numerous biologic and small-molecule drug candidates.

Academic Background

Lisa holds a Bachelor of Science degree in Biochemistry from the University of California, Los Angeles (UCLA). Her academic background has provided a solid foundation for her technical expertise in the regulatory affairs field.

Areas of Expertise

• Global regulatory strategy and planning

• Regulatory submissions and approvals (IND, NDA, BLA)

• Regulatory agency interactions and negotiations

• Cross-functional team leadership and collaboration

• Oncology and immunology product development

Professional Impact

Lisa's regulatory expertise and strategic leadership have been instrumental in advancing several groundbreaking therapies through the development pipeline and onto the market. Her contributions have had a significant impact on improving patient access to innovative treatments and driving the biopharmaceutical industry's progress in addressing unmet medical needs.

Conclusion

With her extensive experience, deep regulatory knowledge, and proven track record of success, Lisa Wax is a highly respected leader in the biopharmaceutical industry. In her current role at IGM Biosciences, she is poised to continue driving the company's regulatory strategy and contributing to the development of transformative therapies that will positively impact the lives of patients worldwide.